Trials / Completed
CompletedNCT06348485
Massive Nasal Bleeding in Patients With NPC Received Curative RT
Massive Nasal Bleeding in Patients With Nasopharyngeal Carcinoma Received Curative Radiotherapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,327 (actual)
- Sponsor
- Taichung Veterans General Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To investigate the incidence, predictive markers, and survival impact of massive nasal bleeding in nasopharyngeal carcinoma (NPC) patients who received curative radiotherapy (RT) with/without chemotherapy. A total of 1327 patients with previously untreated, biopsy-proven NPC, and no distant metastasis were retrospective reviewed. Investigators analyzed the occurrence rates of massive nasal bleeding between different characteristics and tried to identify important predictive factors. Investigators compared overall survival between patients with and without massive nasal bleeding by Kaplan-Meier method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Patients without massive nasal bleeding | No event of massive nasal bleeding after curative radiotherapy |
| OTHER | Patients with massive nasal bleeding | Any event of massive nasal bleeding after curative radiotherapy |
Timeline
- Start date
- 1994-12-01
- Primary completion
- 2019-04-30
- Completion
- 2024-02-29
- First posted
- 2024-04-04
- Last updated
- 2024-04-04
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06348485. Inclusion in this directory is not an endorsement.